KIDS
OrthoPediatrics corp

494
Mkt Cap
$411.52M
Volume
111,068.00
52W High
$32.00
52W Low
$15.28
PE Ratio
-8.39
KIDS Fundamentals
Price
$16.58
Prev Close
$16.41
Open
$16.18
50D MA
$18.77
Beta
1.30
Avg. Volume
235,291.65
EPS (Annual)
-$1.64
P/B
1.18
Rev/Employee
$364,282.92
Loading...
Loading...
News
all
press releases
OrthoPediatrics (KIDS) Reports Q3 Earnings: What Key Metrics Have to Say
Although the revenue and EPS for OrthoPediatrics (KIDS) give a sense of how its business performed in the quarter ended September 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Zacks·7d ago
News Placeholder
More News
News Placeholder
OrthoPediatrics (KIDS) Reports Q3 Loss, Misses Revenue Estimates
OrthoPediatrics (KIDS) delivered earnings and revenue surprises of +7.69% and -2.14%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·7d ago
News Placeholder
Will Glaukos (GKOS) Report Negative Earnings Next Week? What You Should Know
Glaukos (GKOS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks·13d ago
News Placeholder
Earnings Preview: OrthoPediatrics (KIDS) Q3 Earnings Expected to Decline
OrthoPediatrics (KIDS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks·14d ago
News Placeholder
OrthoPediatrics (KIDS) Reports Q2 Earnings: What Key Metrics Have to Say
While the top- and bottom-line numbers for OrthoPediatrics (KIDS) give a sense of how the business performed in the quarter ended June 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Zacks·3mo ago
News Placeholder
OrthoPediatrics (KIDS) Reports Q2 Loss, Misses Revenue Estimates
OrthoPediatrics (KIDS) delivered earnings and revenue surprises of +35.29% and -1.00%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·3mo ago
News Placeholder
The Latest Analyst Ratings For OrthoPediatrics
Latest Ratings for KIDS DateFirmActionFromTo Mar 2022NeedhamMaintainsBuy Dec 2021BTIGMaintainsBuy Dec 2021Truist SecuritiesMaintainsBuy View More Analyst Ratings for KIDS View the...
Benzinga·1y ago
News Placeholder
KIDS Stock Gains From Its New Enabling Technologies Division Launch
OrthoPediatrics Corp. (NASDAQ: KIDS) recently launched its Enabling Technologies division, which will leverage the company's core mission of addressing unmet pediatric needs in orthopedics. read more...
Benzinga·1y ago
News Placeholder
Expert Ratings For OrthoPediatrics
Latest Ratings for KIDS DateFirmActionFromTo Mar 2022NeedhamMaintainsBuy Dec 2021BTIGMaintainsBuy Dec 2021Truist SecuritiesMaintainsBuy View More Analyst Ratings for KIDS View the...
Benzinga·1y ago
News Placeholder
The Analyst Verdict: OrthoPediatrics In The Eyes Of 6 Experts
Latest Ratings for KIDS DateFirmActionFromTo Mar 2022NeedhamMaintainsBuy Dec 2021BTIGMaintainsBuy Dec 2021Truist SecuritiesMaintainsBuy View More Analyst Ratings for KIDS View the...
Benzinga·2y ago

Latest KIDS News

View

Advertisement|Remove ads.

Advertisement|Remove ads.